Refine by
Protein Therapeutics Articles & Analysis: This-Year
4 news found
Creative BioMart, a biotechnology company specializing in cell line development and protein production, has recently upgraded its GMP stable cell line development platform. This platform provides biopharmaceutical companies with a structured and regulatory-compliant approach to develop stable cell lines for therapeutic proteins, monoclonal ...
The topics set for the 2025 edition would highlight small-molecule drug discovery, novel modalities, and translational technologies with a particular focus on targeting protein degradation, RNA therapeutics, and precision drug delivery systems, which are all areas where BOC Sciences has built extensive expertise for years. ...
In drug development, it is used to verify the N-terminal sequences of therapeutic proteins, ensuring proper folding and functionality. In biomarker discovery, it helps characterize N-terminal modifications that may serve as disease markers. For protein engineering, it validates the integrity of recombinant proteins and engineered ...
We look forward to continuing our collaborations and partnerships, contributing to advancements in drug development and improving patient outcomes." mPEG-pALD (20K) plays a vital role in various applications, including the development of therapeutic protein drugs, biosimilars, rare disease treatments, and advanced biomedical research. ...